Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
Capital Bancorp (CBNK) Q3 2026 Earnings: Core Results Hold Steady Ahead of Merger

Capital Bancorp (CBNK) Q3 2026 Earnings: Core Results Hold Steady Ahead of Merger

Key Takeaways

  • Capital Bancorp reported third quarter 2026 GAAP net income of $13.1 million, or $0.80 per diluted share, down from $14.3 million, or $0.87 per share, in the prior quarter.
  • Core (non-GAAP) net income, which excludes $1.6 million in merger-related expenses, was $14.7 million, or $0.89 per diluted share — up 3.2% from the second quarter and 21.0% year over year.
  • Total revenue came in at roughly $68.1 million, modestly below consensus estimates, while core earnings per share (EPS) of $0.89 also landed slightly short of the roughly $0.92 analysts expected.
  • Gross loans grew to about $3.1 billion, up 10.4% year over year, while the net interest margin (NIM) expanded to 5.81% from 5.64% in the prior quarter.
  • The quarter was dominated by a pending all-stock merger with Peoples Bancorp, announced September 29, 2026, along with a planned sale of the company's North Riverside, Illinois branch.

Earnings Context and Why It Matters

Capital Bancorp's third quarter results land at a pivotal moment for the Rockville, Maryland-based community bank. In late September, the company announced it would be acquired by Peoples Bancorp in an all-stock transaction, making this report one of the last standalone snapshots investors will receive before the combination moves toward closing. The numbers matter on two fronts: they show whether the bank's underlying commercial lending, government loan servicing, and OpenSky credit card businesses remained healthy heading into the deal, and they give shareholders a benchmark for judging the roughly $43.75-per-share implied value of the merger. With loan growth accelerating and the net interest margin holding firm, the report offers important clues about the franchise's momentum during a period of transition. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.

Reported Results

Capital Bancorp posted third quarter 2026 GAAP net income of $13.1 million, or $0.80 per diluted share, compared with $14.3 million, or $0.87 per share, in the second quarter and $15.1 million, or $0.89 per share, a year earlier. The decline reflected $1.6 million in merger-related expenses tied to the pending Peoples Bancorp transaction.

On a core, non-GAAP basis — which strips out those merger costs — net income was $14.7 million, or $0.89 per diluted share, up 3.2% sequentially and 21.0% year over year. Total revenue was approximately $68.1 million, modestly below consensus, while core EPS of $0.89 came in slightly under the roughly $0.92 analysts had projected. Net interest income rose to $53.1 million, up 4.2% from the prior quarter, and the net interest margin (NIM) improved to 5.81%. The core NIM excluding the credit card portfolio reached 4.18%, up 14 basis points sequentially. Gross loans grew to about $3.1 billion, up 10.4% year over year, while total deposits declined $52.0 million from the prior quarter on seasonal reductions in title company demand deposit accounts. From what I see, the underlying trends in lending and margins look constructive even with the one-time costs.

Market Reaction and Investor Sentiment

Investor attention around Capital Bancorp's third quarter report has been anchored to the merger announcement rather than the earnings print itself. The September 29 agreement values the company at roughly $43.75 per share in Peoples Bancorp stock, representing a 22.7% premium to its prior closing price. As a result, sentiment has been driven largely by the deal's terms and its path to regulatory and shareholder approval, with the quarterly results serving as a supporting data point. The slight miss on revenue and core EPS was tempered by solid loan growth and a firmer net interest margin. Management's suspension of the stock repurchase program during the pending merger also signals a disciplined, capital-preserving posture ahead of the expected combination.

Forward Outlook and Key Factors to Monitor

Looking ahead, the dominant factor for Capital Bancorp shareholders is the completion of the all-stock merger with Peoples Bancorp. Investors will be watching for regulatory approvals, shareholder votes, and any updates to the transaction timeline, since the final exchange ratio will determine the effective value received.

Beyond the merger, several operating metrics remain worth monitoring. Credit quality will be in focus after the provision for credit losses rose to $4.9 million and net charge-offs reached $3.8 million, or 0.49% of portfolio loans on an annualized basis. The allowance for credit losses coverage ratio stood at 1.78%, and the company reported a healthy Common Equity Tier 1 (CET1) capital ratio of 13.25%, indicating a strong capital position heading into the deal.

Investors should also track the planned sale of the North Riverside, Illinois branch, which is expected to transfer about $111.1 million in deposits. Finally, the trajectory of the net interest margin and government lending fee revenue will provide insight into whether the franchise's earnings power remains intact as the merger process unfolds. Tangible book value per share rose to $23.98, up from $21.33 a year earlier, underscoring the bank's underlying value creation. I'm watching this closely as the deal progresses.

Exploring AI Tools for Deeper Bank Analysis

In my view, tools like Tickeron's AI Screener can help investors quickly compare regional banks on metrics such as loan growth, margins, and capital ratios. I used it to cross-check Capital Bancorp against peers and found the platform's filters useful for spotting patterns in the financial sector without manual digging. This kind of automation supports more efficient research when evaluating merger candidates or sector trends.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CBNK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for CBNK turns positive, indicating new upward trend

CBNK saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 57 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CBNK just turned positive on September 30, 2026. Looking at past instances where CBNK's MACD turned positive, the stock continued to rise in 22 of 44 cases over the following month. The odds of a continued upward trend are 50%.

CBNK moved above its 50-day moving average on September 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CBNK crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +1.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBNK advanced for three days, in 192 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 107 of 230 cases where CBNK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 47%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBNK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

CBNK broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 26 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. CBNK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.609) is normal, around the industry mean (1.272). P/E Ratio (12.155) is within average values for comparable stocks, (13.289). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (1.190). Dividend Yield (0.013) settles around the average of (0.035) among similar stocks. P/S Ratio (2.411) is also within normal values, averaging (3.738).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Itau Unibanco Banco Holding SA (NYSE:ITUB), US Bancorp (NYSE:USB), PNC Financial Services Group (NYSE:PNC), Deutsche Bank Aktiengesellschaft (NYSE:DB), Banco Bradesco SA (NYSE:BBD), Huntington Bancshares (NASDAQ:HBAN), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.21B. The market cap for tickers in the group ranges from 148.11 to 173.74B. DBSDF holds the highest valuation in this group at 173.74B. The lowest valued company is VLYPP at 148.11.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was 3%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 9%. EGBN experienced the highest price growth at 19%, while AGBK experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 181%. For the same stocks of the Industry, the average monthly volume growth was 233% and the average quarterly volume growth was 233%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 51
Price Growth Rating: 48
SMR Rating: 37
Profit Risk Rating: 56
Seasonality Score: 56 (-100 ... +100)
View a ticker or compare two or three
CBNK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a major bank

Industry RegionalBanks

Industry
Major Banks
Address
2275 Research Boulevard
Phone
+1 301 468-8848
Employees
459
Web
https://www.capitalbankmd.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.